OnKure Therapeutics

(NASDAQ) OKUR

Current Price$4.26

Market Cap$171.68M

Since IPO (2024)-77%

5 YearN/A

1 Year+48%

1 Month+9%

OnKure Therapeutics Financials at a Glance

Market Cap

$171.68M

Revenue (TTM)

$0.00

Net Income (TTM)

-$58.75M

EPS (TTM)

-$4.33

P/E Ratio

-0.98

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$4.26

Volume

1,829

Open

$4.21

Price

$4.26

Volume

1,829

Open

$4.21

Previous Close

$4.25

Daily Range

$4.18 - $4.40

52-Week Range

$1.91 - $5.38

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$4.26

Volume

1,829

Open

$4.21

Previous Close

$4.25

Daily Range

$4.18 - $4.40

52-Week Range

$1.91 - $5.38

Estimated Earnings Date

Aug 11, 2026

OKUR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OnKure Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Nicholas A. Saccomano, PhD

Website

onkuretherapeutics.com

Headquarters

Boulder, CO 80301, US

OKUR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-43%

Return on Capital

-33%

Return on Assets

-30%

Earnings Yield

-1.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$171.68M

Shares Outstanding

40.40M

Volume

1.83K

Avg. Volume

338.16K

Financials (TTM)

Gross Profit

-$830.00K

Operating Income

-$62.95M

EBITDA

-$62.12M

Operating Cash Flow

-$51.83M

Capital Expenditure

-$46.00K

Free Cash Flow

-$51.87M

Cash & ST Invst.

$59.05M

Total Debt

$549.00K

OnKure Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$203.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$171.68M

N/A

Market Cap/Employee

$3.73M

N/A

Employees

N/A

Net Income

-$15.16M

+4.8%

EBITDA

-$15.41M

+8.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$191.70M

+100.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$409.00K

-25.1%

Return on Assets

-29.57%

N/A

Return on Invested Capital

-33.39%

N/A

Free Cash Flow

-$12.94M

+7.7%

Operating Cash Flow

-$12.94M

+7.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MRSNMersana Therapeutics, Inc.

MRSNMersana Therapeutics, Inc.$29.08+0.00%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$1.09+5.34%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$7.80-1.33%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$5.12-0.39%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.66-8.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

DSYBig Tree Cloud

DSYBig Tree Cloud$9.02+3.90%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.41-0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.16+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.21-0.06%

MRVLMarvell Technology

MRVLMarvell Technology$255.74-0.04%

NVDANvidia

NVDANvidia$203.45-0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$33.20-0.18%

Questions About OKUR

What is the current price of OnKure Therapeutics?

OnKure Therapeutics is trading at $4.26 per share.

What is the 52-week range for OnKure Therapeutics?

Over the past 52 weeks, OnKure Therapeutics has traded between $1.91 and $5.38.

How much debt does OnKure Therapeutics have?

As of the most recent reporting period, OnKure Therapeutics reported total debt of $409.00K.

How much cash does OnKure Therapeutics have on hand?

OnKure Therapeutics reported $192.11M in cash and cash equivalents in its most recent financial results.

What is OnKure Therapeutics’s dividend yield?

OnKure Therapeutics does not currently have a dividend yield.

OnKure Therapeutics

OnKure Therapeutics Financials at a Glance

OKUR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About OnKure Therapeutics

OKUR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

OnKure Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OKUR

What is the current price of OnKure Therapeutics?

What is the 52-week range for OnKure Therapeutics?

How much debt does OnKure Therapeutics have?

How much cash does OnKure Therapeutics have on hand?

What is OnKure Therapeutics’s dividend yield?

Premium Investing Services